retinol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

retinol has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abletshauser, C; Hanefeld, M; Jaross, W; Kurktschiev, T; Lattke, P; Leonhardt, W; Meissner, D; Weidinger, G1

Trials

1 trial(s) available for retinol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals.
    European journal of clinical pharmacology, 1997, Volume: 53, Issue:1

    Topics: Anticholesteremic Agents; Antioxidants; Double-Blind Method; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Metals; Middle Aged; Vitamin A; Vitamin E

1997